This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Cancer Research Technology Limited. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Justin Bower: Innovator in Cancer Research
Introduction
Justin Bower is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of cancer research, holding 3 patents that focus on innovative therapeutic compounds. His work aims to address various proliferative diseases, including cancer.
Latest Patents
Bower's latest patents include "Bicyclic nitrogen containing heterocycles as inhibitors of salt-induced kinase SIK2." This invention provides compounds that are effective inhibitors of salt-inducible kinase (SIK), particularly SIK2, and are useful in treating a range of disorders such as proliferative diseases, inflammatory conditions, and neurological disorders. Another significant patent is "Pyrrolo[2,3-b]pyridine compounds and their use in the treatment of cancer." This application relates to compounds that exhibit pharmacological effects, particularly at MRCK, and are intended for the treatment and prevention of proliferative diseases like cancer.
Career Highlights
Justin Bower is currently associated with Cancer Research Technology Limited, where he continues to develop innovative solutions for cancer treatment. His research is pivotal in advancing therapeutic options for patients suffering from various forms of cancer.
Collaborations
Bower collaborates with esteemed colleagues such as Mairi Sime and Angelo Pugliese, contributing to a dynamic research environment focused on cancer therapies.
Conclusion
Justin Bower's contributions to cancer research through his innovative patents highlight his commitment to improving therapeutic options for patients. His work continues to inspire advancements in the field of oncology.